is common for patients to reveal a leukocytosis (increased WBC count) within 24
hours of initiation of a glucocorticoid. It is important for clinicians
to be aware of this expected side effect and to understand the rationale for
such an increase as well as appropriate interpretation of the labs given the
patient's clinical condition. Keeping all of these things in mind will
help clinicians avoid unnecessary medical work-up for other conditions and
avoid patient exposure to additional drug therapy that is not warranted, such
as intravenous antibiotics.